Drug intelligence / Profile preview

89Zr-16A

Development stage
Phase 1
Lead developer
ImaginAb
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Monoclonal Antibodies → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

**89Zr-16A** is an investigational zirconium-89 radiolabeled 16A monoclonal-antibody immunoPET tracer for molecular imaging of tumors expressing an aberrantly glycosylated MUC1 neoantigen. The 16A antibody recognizes a GSTA glycosite-signature epitope within the MUC1 tandem-repeat region, with preferential uptake and internalization reported in COSMC-deficient MUC1-expressing tumor cells. The tracer is intended for PET/CT-based detection and characterization of MUC1-positive solid tumors, with a gastric-cancer-focused, phase-not-specified diagnostic clinical study registered as NCT06429891. ([jnm.snmjournals.org](https://jnm.snmjournals.org/content/65/supplement_2/242030))

Other names
89 Zr-16A89Zr-16A89Zr-labeled 16A
02

Targets

MUC1-N (Mucin-1 subunit alpha)

Beyond the preview

Go deeper on 89Zr-16A.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 89Zr-16A.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call